We use cookies to enhance your experience. By clicking "Accept All," you consent to the use of cookies. Learn more
Relvar Ellipta is a prescription-only inhaler used in the management of asthma and chronic obstructive pulmonary disease (COPD). It contains a combination of fluticasone furoate (a corticosteroid) and vilanterol (a long-acting bronchodilator) to help reduce inflammation and keep airways open for easier breathing.
Contains fluticasone furoate and vilanterol for effective asthma and COPD management
Helps reduce inflammation and improve breathing
Once-daily inhaler for convenient use
Suitable for adults and adolescents as prescribed
Provides a measured and consistent dose with each inhalation
Relvar Ellipta should be used exactly as prescribed by your healthcare professional. Regular use helps prevent asthma attacks and manage COPD symptoms. The inhaler delivers a precise dose each time, ensuring effective and reliable treatment.
This is a prescription-only medicine (POM). Use only under medical supervision. Do not exceed the prescribed dose. If symptoms worsen or if you experience side effects, seek medical advice immediately.